CryoCor, Inc. - Investor Relations

Corporate Information

Management

Corporate Governance

Board of Directors

Committees & Charters

Policy Regarding Stockholder Recommendations of Director Nominees

Code of Business Conduct and Ethics

Insider Transactions

Insider Ownership

Press Releases

Events & Presentations

Financial Information

Quarterly Results

Annual Reports

SEC Filings

Key Ratios

Stock Information

Stock Performance

Historic Stock Lookup

Investment Calculator

Analyst Coverage

Shareholder Services

Investor FAQs

Contact Us

Home > Investors

Investor Relations

March 20, 2008
CryoCor 2007 Year End Results Conference Call

Genesis Medical Center Cryoablation Video
Courtesy of CBS4 WHBF-TV, Rock Island, IL.
Click here to view.

CryoCor, Inc. is a medical technology company headquartered in San Diego, California developing products that use cryogenic technology to treat cardiac rhythm disorders called arrhythmias. Cardiac cryoablation is a non-surgical, minimally-invasive procedure in which a cardiologist inserts a catheter into a blood vessel in the leg of an afflicted individual and advances it into the heart. Once it reaches the targeted cardiac tissue, the catheter tip temperature is lowered to approximately -90°C — thereby blocking the conduction of the abnormal signals causing the heart to beat inappropriately and restoring its function to normal.

Recent Releases

May 16, 2008
CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger

Apr 16, 2008
Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement

Events

Mar 20, 2008
CryoCor 2007 Year End Results Conference Call

Jan 17, 2008
Stanford Group 13th Annual Healthcare Conference

Stock Information

CRYO - (NASD)
$1.35 + 0.01

May 29, 2008
5:51 AM ET